3
10
E. G. Ferrer et al. · ALP Inhibitors: Vanadyl(IV) Complexes of Ferulic and Cinnamic Acid
tivity. This behavior has been documented for a few The results obtained with the series of carboxy-
vanadium complexes and the lack of inhibitory activity late/VO complexes suggest:
upon phosphatases is explained by compound break-
• that the complexes having a set of hard donor
−
down in solution. However, the compounds are sup- ligands like COO and O (quinate) or CH O
−
−
3
posed to be inhibitors if the effect is determined un- (from methoxide in the cinnamate complex), that
der conditions where they remain intact [38]. It has forms particularly strong complexes with the vanadyl
been demonstrated [36] that the potency of the enzy- cation [40] better adopt the transition state structure
matic inhibition of the vanadium compounds varies of ALP, being in this way stronger inhibitors than the
considerably depending on the ancillary ligands. In- other ones.
creasing the bulkiness of the ligands by introducing
sustituents significantly decreased the inhibitory effect plex may be attributed to the lability of the coordinated
on the ALP activity. Vanadium compounds having 6- methanol molecules. The complex is thermally unsta-
• that the effect observed for the VO/Ferulic com-
◦
coordinate octahedral geometry display the lower inhi- ble (methanol is lost at 103 C) denoting weak coor-
bition on ALP activity [38].
dination to the vanadyl(IV) cation. This fact suggests
The inhibitory effect of vanadium compounds on a reduction of the possibility to adopt the appropriate
the activity of the enzymes that catalyze phosphoryl transition state symmetry in the interaction with the en-
group transference can be attributed to the formation of zyme in aqueous solution.
a trigonal bipyramidal transition state analogue. These
phosphorus-mimicking vanadium compounds, with a Conclusions
structure closer to the transition state than that of the
phosphorus compounds, likely fit more tightly into the
Two new vanadyl(IV) complexes with naturally oc-
curring ligands have been prepared and characterized.
active site, causing inhibition of the enzymatic reac- Their inhibitory effect upon specific alkaline phos-
tion [37]. Although the trigonal bipyramidal coordi- phatase activity shows a different behavior probably
nation geometry is usual for vanadium(V) but not for associated with the lability of the ligands in the coordi-
nation sphere. Ferulic and cinnamic acids do not exert
inhibition on the enzyme, an effect that was previously
determined for quinic and caffeic acids upon glucose-
the vanadyl(IV) cation, it has been recently demon-
strated that this coordination structure can be attained
by VO2+ in the presence of flexible ligands such as
6-phophatase as stated in the introductory section.
proteins and enzymes [22, 39]. However, in a recent
study it has been suggested that the best bioavailability Acknowledgements
rather than the increased potency at the phosphatase
This work was supported by CONICET, CICPBA, UNLP
enzyme active sites of vanadyl(IV) complexes com- and ANPCyT (PICT 06-06148). EGF is a member of the Re-
pared with inorganic vanadium, would be the cause of search Career from CONICET. PAMW is a member of the
their higher insulin mimetic activities [7].
Research Career from CICPBA.
[
[
[
1] E. J. Baran, J. Inorg. Biochem. 80, 1 (2000).
[9] C. Slebodnick, B. J. Hamstra, V. L. Pecoraro, Struct.
Bonding 89, 51 (1997)
[10] P. A. M. Williams, D. A. Barrio, S. B. Etcheverry, J. In-
org. Biochem. 75, 99 (1999).
2] P. W. Linder, A. Voy e´ , Polyhedron 6, 53 (1987).
3] Y. Kono, S. Kashine, T. Yoneyama, Y. Sakamoto,
Y. Matsui, H. Shibata, Biosci. Biotechnol. Biochem.
6
2, 22 (1998).
4] R. Bakhtiar, E. I. Ochiai, Gen. Pharmacol. Vasc. S 32,
25 (1999).
5] B. R. Cameron, I. R. Baird, J. Inorg. Biochem. 83, 233
2001).
[11] K. H. Thompson, C. Orvig, J. Chem. Soc., Dalton
Trans. 2885 (2000).
[
[
5
[12] S. B. Etcheverry, D. A. Barrio, P. A. M. Williams, E. J.
Baran, Biol. Trace Elem. Res. 84, 227 (2001).
[13] W. Fiddler, W. E. Parker, A. E. Wasserman, R. C. Do-
err. J. Agr. Food Chem. 15, 757 (1967) and references
therein.
[14] K. L. Johnston, M. N. Clifford, L. M. Morgan, Am. J.
Clin. Nutr. 78, 728 (2003).
[15] H. Hemmerle, H. Burger, P. Below, G. Schubert,
R. Rippel. J. Med. Chem. 40, 137 (1997).
[16] P. W. Schindler, P. Below, H. Hemmerle, H. Burger,
(
[
[
6] D. C. Crans. J. Inorg Biochem. 80, 123 (2000).
7] K. G. Peters, M. G. Davis, B. W. Howard, M. Pokross,
V. Rastogi, C. Diven, K. D. Greis, E. Eby-Wilkens,
M. Maier, A. Evdokimov, S. Soper, F. Genbauffe, J.
Inorg. Biochem. 96, 321 (2003).
[
8] D. C. Crans, J. J. Smee, E. Gaidamauskas, L. Yang,
Chem. Rev.104, 849 (2004).
Unauthenticated
Download Date | 10/4/18 9:02 PM